Neurodegenerative Drug Development Summit

Conference themes
Returning to Boston in February 2020 is the 8th Neurodegenerative Drug Development Summit, previously World CNS.

Despite the lack of clinical trial success, new investments are being made in forward-thinking biotechs, digital and blood-based biomarker technologies are advancing, new targets are emerging, and gene therapy is taking the limelight.

Professional congress organizer (PCO)
Hanson Wade

Notes
URLs:
Brochure: https://go.evvnt.com/552917-3?pid=4832
Booking: https://go.evvnt.com/552917-4?pid=4832
Inquiries: https://go.evvnt.com/552917-5?pid=4832

Speakers: Larry Brown, Executive Vice President and Chief Scientific Officer, others

https://go.evvnt.com/552917-1?pid=4832

Ms. Sophie Ellis